CD4 and neoplasm: TIICs in the tumor microenvironment also influence tumor prognosis; for example, patients with thymoma with high infiltrating levels of B, CD4+ and dendritic cells (DCs) have a better prognosis and may be partially regulated by the ASF1B gene (12).